Skip to main content

Meeting of the committee for community and environmental development at the Faculty of Pharmacy to be held on Sunday, November 8, 2026.

God willing, a meeting of the committee for community and environmental development of the Faculty to be held on Sunday, November 8, 2026, at 11:00 AM

This will take place in the office of Professor Dr./ Vice Dean of the Faculty for Community Service and Environmental Development to discuss the topics outlined in the agenda that will be presented at that time.

news category
خبر عام

Meeting of the Department of Pharmaceutical Chemistry Council, Faculty of Pharmacy, to be held on Wednesday, November 4, 2026.

God willing, the 504st meeting of the Department of Pharmaceutical Chemistry Council at the Faculty of Pharmacy to be held on Wednesday, November 4, 2026., at 9:00 AM in the department library.

news category
خبر عام

Invitation to Attend a Master's Thesis Seminar (Second Seminar) in the Department of Pharmacognosy – Pharmacist / Nadeen Hatem Ahmed Diab

By the Grace of Allah, a scientific discussion seminar (Second Seminar) for the Master’s thesis of Pharmacist / Nadeen Hatem Ahmed Diab, Demonstrator at the Department, will be held on Thursday, November 5, 2026, in partial fulfillment of the requirements for the Master’s Degree in Pharmaceutical Sciences (Pharmacognosy).

Thesis Title:

Pharmacognostical and biological studies of Roystonea regia (Kunth) O.F. Cook. Family Arecaceae, cultivated in Assiut.

Venue & Time:

The seminar will take place in the Meeting Room at the Department of Pharmacognosy at 10:00 AM.

Opening of the Appeals Process for Postgraduate Students for the Second Semester (November 1 to 5, 2026)

Please be informed that the appeals process for postgraduate students for the second semester is now open, starting from Sunday, November 1, 2026, until Thursday, November 5, 2026. All appeals must be submitted directly to the Postgraduate Studies Administration at the faculty. 

 

news category
إعلانات الدراسات العليا

New oxa/thiadiazole-chalcone hybrids linked via a clickable 1, 2, 3-triazole bridge with dual EGFR/VEGFR-2 kinase inhibitory activity and antiproliferative effects

Research Abstract

The growing global incidence of cancer, coupled with the limitations of many current therapies, such as cytotoxicity, resistance, and poor selectivity, drives the need for new therapeutic agents. In this study, a novel series of pyridine-1,3,4-oxa/thiadiazole-chalcone hybrids, linked via a clickable 1,2,3-triazole moiety (7a-k and 8a-d), were synthesized and elucidated by FT-IR, NMR, and HRMS. These target compounds were screened in vitro for anticancer activity against three human cancer cell lines (A549, MCF-7, HCT-116) and for EGFR/VEGFR-2 inhibitory activity. The HCT-116 cells were the most sensitive. Notably, compounds 7b, 7d, 7j, 8b, and 8d exhibited promising cytotoxic activity with IC50 values ranging from 0.79 to 19.23 μM against the three tested cell lines. Moreover, the safety of derivatives 7b, 7d, 7f, 7j, 8b, and 8d was confirmed by screening them against a normal colon cell line (FHC), which exhibited a favorable selectivity profile within the HCT-116/FHC model. Additionally, compounds 7d and 8d showed inhibitory activity against EGFRWT (0.084, 0.068 μM, respectively), EGFRT790M (0.287 ± 0.01, 0.154 ± 0.004 μM, respectively), and VEGFR-2 (0.075, 0.071 μM, respectively). Compound 7d exhibited potent inhibitory activity against resistant NCI-H1975 cell line, with an IC₅₀ value of 11.64 ± 0.31 μM. Against SW1463 cells, 7d and 8d showed IC₅₀ of 2.74 ± 0.08 and 7.180 ± 0.23 μM, respectively, outperforming erlotinib (IC₅₀ = 12.335 ± 0.40 μM). Compound 8d exhibited potent inhibition of both EGFRT790M and EGFRWT expression, reducing their levels to 2.164 ± 0.08 ng/mL (78.8% reduction) and 220.88 ± 8.33 pg/mL (76.0% reduction), respectively, showing activities comparable to erlotinib. Compounds 7d, 7j, 8b, and 8d appeared to induce cell cycle arrest at G₀/G₁ phase and promote apoptosis; however, these findings are preliminary, derived from a single experiment, and hypothesis-generating. Computational studies for the most active compounds showed configurations that were pose-consistent with key hinge interactions within the target enzymes. Furthermore, the lipophilicity (log P) of the compounds, 7f and 8d 

Research Authors
M El-Qommos, RMI Morsy, HM Abdel-Rahman, MA Hussein, YA Mostafa
Research Date
Research Journal
Bioorganic Chemistry
Research Pages
110453
Research Publisher
Elsevier
Research Rank
Q1
Research Year
2026

Announcement of holding the second scientific symposium to discuss a master’s thesis in the Department of Pharmaceutical Organic Chemistry - Faculty of Pharmacy, Assiut University

The Department of Pharmaceutical Organic Chemistry announces a second scientific symposium to present the content of the master’s thesis 

By Mrs. Pharmacist Nouran Hamdi Naguib

Teaching assistant in the department to obtain a master’s degree in pharmaceutical sciences (pharmaceutical organic chemistry).

 

Symposium title

 

"Design, synthesis, computational studies, and comprehensive biological evaluation of novel hybrid molecules as dual aromatase inhibitors and ERα modulators"

 

Date & Location:

• Day and date: Thursday, 10/22/2026 AD

• Time: eleven o’clock in the morning

• Location: In the department’s auditorium

news category
قسم الكيمياء العضوية
Subscribe to